Agricultural University of Athens
Γενετική αλληλεπίδραση της πρωτεΐνης Tau με πρωτεΐνες δέσμευσης ακτίνης in vivo
Abstract
dc:descriptionThe accumulation of pathological Tau is a defining feature of Alzheimer’s disease and related tauopathies, yet the molecular events that drive this normally highly soluble protein towards aggregation in vivo remain poorly understood. Although Tau is extensively modified post-translationally, the contribution of redox regulation to its physiological function and pathogenic conversion has received comparatively limited attention.Human Tau contains two cysteine residues, Cys291 and Cys322, within its microtubule-binding domain. Both residues have been implicated in Tau conformation and self-assembly, but their individual functions in vivo have remained unclear. Using the established Drosophila melanogaster model of tauopathy, wild-type human Tau was compared with variants in which either cysteine was replaced by alanine. The contribution of each residue to Tau stability, phosphorylation, cytoskeletal interactions, aggregation, stress responses, neurotoxicity, and cognitive function were examined. In parallel, the flavoprotein monooxygenase Mical was investigated as a potential redox regulator of Tau.Cys291 and Cys322 were found to perform distinct functions. Cys291 influenced selected properties of Tau, whereas Cys322 had a broader role, regulating Tau stability, interactions with both microtubules and F-actin, aggregation, stress sensitivity, neurotoxicity, and cognitive dysfunction. These findings identify Cys322 as a major molecular determinant of Tau pathogenicity in vivo.Mical was identified as an interacting partner of human Tau in the Drosophila CNS. Increasing Mical levels enhanced Cys322 oxidation, reduced the affinity of Tau for microtubules, promoted its association with F-actin, and shifted Tau towards insoluble species. These biochemical changes were accompanied by increased neurotoxicity and cognitive impairment. Conversely, genetic suppression of Mical reduced Tau-induced toxicity and restored memory performance. The effects required the redox activity of Mical and were abolished or markedly reduced in the C322A Tau variant, establishing Cys322 as a redox-sensitive regulatory hub through which Mical modulates Tau function and pathogenicity.The mechanism was shown to be evolutionarily conserved. Human MICAL1 functionally substituted for Drosophila Mical, interacted with human Tau, and enhanced Tau aggregation and neuronal dysfunction in a Cys322-dependent manner. Moreover, MICAL1 levels were elevated in human brain samples from patients with Tauopathies, and MICAL1 co-localized with Tau in Pick bodies. Collectively, these findings define an evolutionarily conserved Tau-MICAL axis that links Cys322 redox regulation to Tau cytoskeletal interactions, aggregation, neurotoxicity, and neuronal dysfunction.
Degree
thesis:*- Grantor dc:publisher
- Agricultural University of Athens
- Year dc:date
- 2026
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Priftaj, Enxhi
- Πρίφτη, Έντζι
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/62969